Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase

Xiaoyong Fu, Chad J. Creighton, Nrusingh C. Biswal, Vijetha Kumar, Martin Shea, Sabrina Herrera, Alejandro Contreras, Carolina Gutierrez, Tao Wang, Sarmistha Nanda, Mario Giuliano, Gladys Morrison, Agostina Nardone, Kristen L. Karlin, Thomas F. Westbrook, Laura M. Heiser, Pavana Anur, Paul Spellman, Sylvie M. Guichard, Paul D. SmithBarry R. Davies, Teresa Klinowska, Adrian V. Lee, Gordon B. Mills, Mothaffar F. Rimawi, Susan G. Hilsenbeck, Joe W. Gray, Amit Joshi, C. K. Osborne, Rachel Schiff

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint Dive into the research topics of 'Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase'. Together they form a unique fingerprint.

Medicine & Life Sciences